PARSIPPANY, N.J. / Mar 13, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies. In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of three pharmaceutical companies and the only standalone animal health company included on the list.
“We are truly honored to be recognized by Ethisphere on their prestigious World’s Most Ethical Companies list,” said Kristin Peck, CEO of Zoetis. “Our culture is firmly grounded in our Core Beliefs, which guide our achievements, actions and behaviors every day. I am especially proud of our colleagues around the world, whose uncompromising commitment to integrity is at the heart of everything we do to nurture the world and humankind by advancing animal care.”
Grounded in Ethisphere’s proprietary Ethics Quotient®, the World’s Most Ethical Companies assessment process includes more than 200 questions on culture, environmental and social practices, ethics and compliance activities, governance, diversity, and initiatives that support a strong value chain. The process serves as an operating framework to capture and codify the leading practices of organizations across industries and around the globe. Ethisphere’s 2023 Ethics Index, the collection of publicly traded companies recognized as recipients of this year’s World’s Most Ethical Companies designation, outperformed a comparable index of large-cap companies by 13.6 percentage points over a five-year period.
“At Zoetis, integrity is the foundation of how we operate, how we deliver our objectives, and how we treat our customers, colleagues and communities,” said Jeff Williams, Chief Compliance Officer at Zoetis. “In today’s dynamic marketplace, it’s more important than ever for companies and leaders to put ethical conduct at the center of their business practices. We have done this at Zoetis, and I am thrilled to see us recognized by Ethisphere for our exceptional programs that advance business integrity.”
Learn more
To view the full list of this year’s honorees, visit the World’s Most Ethical Companies website at https://worldsmostethicalcompanies.com/honorees.
To learn more about Zoetis’ award-winning culture and Corporate Compliance Program, visit www.zoetis.com.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.
About Ethisphere
Ethisphere is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust, and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character. Ethisphere honors superior achievement through its World’s Most Ethical Companies® recognition program, provides a community of industry experts with the Business Ethics Leadership Alliance (BELA), and showcases trends and best practices in ethics with Ethisphere Magazine. Ethisphere also helps to advance business performance through data-driven assessments, guidance, and benchmarking against its unparalleled data: the Culture Quotient dataset focused on ethical culture and featuring the responses of 2+ million employees around the world; and the Ethics Quotient dataset, featuring 200+ data points highlighting the ethics, compliance, social, and governance practices of the World’s Most Ethical Companies. For more information, visit https://ethisphere.com.
Last Trade: | US$176.96 |
Daily Change: | 0.25 0.14 |
Daily Volume: | 1,754,854 |
Market Cap: | US$79.840B |
November 04, 2024 September 26, 2024 August 06, 2024 May 02, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB